Oncocross Completes Phase 1 Global Clinical Trial of OC514, Treatment for Sarcopenia

Accelerates a new drug development for sarcopenia through its unique AI platform

11/05/2023 14:45:17
anti-spam
0 / 300

106 West 32nd Street, New York, NY 10001 | Copyright ©Tech Seoul All Rights Reserved